Luteolin attenuates the chemoresistance of osteosarcoma through inhibiting the PTN/β-catenin/MDR1 signaling axis by upregulating miR-384
Author:
Funder
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Oncology
Reference46 articles.
1. Osteosarcoma: a review of current and future therapeutic approaches;Zhao;Biomed. Eng. Online,2021
2. Luteolin, a flavonoid with potential for cancer prevention and therapy;Lin;Curr. Cancer Drug Targets,2008
3. Luteolin, inflammation and cancer: special emphasis on gut microbiota;Franza;BioFactors,2021
4. Reversal of doxorubicin-induced cardiotoxicity by using phytotherapy: a review;Hosseini;J. Pharmacopuncture,2017
5. Luteolin, a flavonoid, as an anticancer agent: a review;Imran;Biomed. Pharmacother.,2019
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The potential role of luteolin, a flavonoid in cancer prevention and treatment;CyTA - Journal of Food;2024-07-24
2. RECENT INSIGHTS INTO LUTEOLIN AND ITS BIOLOGICAL AND PHARMACOLOGICAL ACTIVITIES;EXCLI J;2024
3. Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches;Phytotherapy Research;2023-12-13
4. miRNAs as short non-coding RNAs in regulating doxorubicin resistance;Journal of Cell Communication and Signaling;2023-11-29
5. Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma;Cancer Cell International;2023-09-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3